A detailed history of Wakefield Asset Management Lllp transactions in Pfizer Inc stock. As of the latest transaction made, Wakefield Asset Management Lllp holds 16,416 shares of PFE stock, worth $438,963. This represents 0.16% of its overall portfolio holdings.

Number of Shares
16,416
Previous 16,219 1.21%
Holding current value
$438,963
Previous $453,000 4.86%
% of portfolio
0.16%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$27.7 - $31.39 $5,456 - $6,183
197 Added 1.21%
16,416 $475,000
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $409,691 - $480,082
16,219 New
16,219 $453,000
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $1.66 Million - $1.96 Million
-35,614 Reduced 94.27%
2,163 $113,000
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $49,776 - $61,678
-1,088 Reduced 2.8%
37,777 $1.96 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $13,429 - $19,906
-325 Reduced 0.83%
38,865 $2.3 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $77,087 - $99,024
1,964 Added 5.28%
39,190 $1.69 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $1.34 Million - $1.51 Million
37,226 New
37,226 $1.46 Million
Q3 2019

Oct 25, 2019

SELL
$32.49 - $42.13 $3,119 - $4,044
-96 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $27,365 - $30,724
-740 Reduced 88.52%
96 $4,000
Q1 2019

May 06, 2019

SELL
$37.5 - $41.2 $290,775 - $319,464
-7,754 Reduced 90.27%
836 $36,000
Q4 2018

Feb 15, 2019

SELL
$38.47 - $43.86 $46,394 - $52,895
-1,206 Reduced 12.31%
8,590 $375,000
Q3 2018

Nov 15, 2018

BUY
$34.47 - $41.81 $337,668 - $409,570
9,796 New
9,796 $432,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.